✦ LIBER ✦

G.P.3.05 Phase 2 study of PTC124 for nonsense mutation suppression therapy of Duchenne muscular dystrophy (DMD)

✍ Scribed by C. Bönnemann; R. Finkel; B. Wong; K. Flanigan; J. Sampson; L. Sweeney; A. Reha; G. Elfring; L. Miller; S. Hirawat

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

P3.51 Results of a Phase 2b, dose-rangin

✍ R. Finkel; B. Wong; K. Bushby; A. Reha; G.L. Elfring; L.L. Miller; J. Babiak; M. 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 50 KB

T.P.3.05 Reproducibility and correlation

✍ J. Florence; R.T. Abresch; M. Eagle; E. Gappmaier; A.M. Glanzman; E. Henricson; 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 54 KB

T.P.5.01 Phase 2b Study of PTC124 in Duc

✍ L.A. Atkinson; A.L. Reha; G.L. Elfring; R. Finkel; B. Wong; K. Flanigan; C.M. Mc 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 48 KB

M.P.3.05 Use of a novel system for gradi

✍ M. Elfring; R.T. Abresch; J. Florence; E. Gappmaier; A.M. Glanzman; E. Henricson 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 43 KB

P.11.19 Phase 2b, dose-ranging study of

✍ McDonald, C.M.; Henricson, E.K.; Abresch, R.T.; Elfring, G.L.; Barth, J.; Peltz, 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 50 KB